| abstract |
Genetically modified compositions such as adeno-associated virus vectors and primary cells for the treatment of various conditions and diseases. Modified adeno-associated viruses for the treatment of cancer are also disclosed. In addition, methods of making and using genetically modified compositions in the treatment of various diseases, conditions, and cancers are also disclosed. [Selection diagram] FIG. 24A |